| Literature DB >> 27214214 |
Abstract
Entities:
Keywords: dosage of clotting factor; gene therapy; hepatitis; human immunodeficiency virus (HIV); inhibitors; prophylaxis for haemophilia; viral safety
Year: 1995 PMID: 27214214 DOI: 10.1111/j.1365-2516.1995.tb00032.x
Source DB: PubMed Journal: Haemophilia ISSN: 1351-8216 Impact factor: 4.287